Nadroparin Nearly Halves Risk Of Developing Blood Clots In Ambulatory Cancer Patients Receiving Chemotherapy

Nadroparin Nearly Halves Risk...

September 1, 2009
1 Star2 Stars3 Stars4 Stars5 Stars
(4 votes, average: 3.75 out of 5)
Loading ... Loading ...

An article published Online First and in the October edition of The Lancet Oncology reports that the blood-thinning drug nadroparin halves the risk of developing blood clots in ambulatory cancer patients…

watches